You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

OSI-774

Showing 1 - 25 of 240
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

Active, not recruiting
  • Adult Solid Neoplasm
  • Erlotinib Hydrochloride
  • Irinotecan Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Liver Cancer Trial in Houston (Bevacizumab, Erlotinib)

Completed
Has Results
  • Liver Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 3, 2022

Lung Cancer Trial in New Haven, Houston (Erlotinib, AZD6244, MK-2206)

Completed
Has Results
  • Lung Cancer
  • New Haven, Connecticut
  • +1 more
Dec 14, 2021

Lung Cancer Trial in Houston (DOTAP:Chol-TUSC2, Erlotinib, Dexamethasone)

Terminated
  • Lung Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 11, 2022

Cirrhosis, Hepatocellular Carcinoma Trial in United States (Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis)

Active, not recruiting
Has Results
  • Cirrhosis
  • Hepatocellular Carcinoma
  • Jacksonville, Florida
  • +5 more
Feb 24, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 15, 2021

Recurrent NSCLC Trial in Sacramento, San Francisco (INC280, erlotinib HCl)

Completed
  • Recurrent Non-small Cell Lung Cancer
  • Sacramento, California
  • +1 more
Oct 11, 2021

NSCLC, Brain Cancer Trial in Tucson, Houston (Tarceva (Erlotinib HCl), Radiation Therapy)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Brain Cancer
  • Tarceva (Erlotinib hydrochloride)
  • Radiation Therapy
  • Tucson, Arizona
  • +1 more
Sep 14, 2021

Head Neck Cancer Trial in Houston (drug, other, behavioral)

Active, not recruiting
  • Head and Neck Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 31, 2022

Breast Cancer Trial in Los Angeles (trastuzumab, erlotinib HCl)

Completed
Has Results
  • Breast Cancer
  • trastuzumab
  • erlotinib hydrochloride
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Sep 17, 2020

Lung Cancer Trial in Cleveland (drug, procedure, radiation)

Completed
Has Results
  • Lung Cancer
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 17, 2020

Non-Small-Cell Lung Carcinoma Trial in Boston (OSI-774 (Tarceva))

Completed
  • Non-Small-Cell Lung Carcinoma
  • OSI-774 (Tarceva)
  • Boston, Massachusetts
  • +1 more
Apr 1, 2020

Solid Tumors, Advanced Cancer Trial in Houston (Anastrozole, Bevacizumab, Everolimus)

Completed
  • Solid Tumors
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 20, 2021

NSCLC Trial in Bronx, New York (Tarceva)

Completed
  • Non-Small Cell Lung Cancer
  • Bronx, New York
  • +3 more
Dec 26, 2019

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in San Francisco, Columbus

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +3 more
  • erlotinib hydrochloride
  • +2 more
  • San Francisco, California
  • +1 more
Jul 29, 2020

Adenocarcinoma, NSCLC Trial in Boston (Erlotinib)

Completed
Has Results
  • Adenocarcinoma
  • Non-small Cell Lung Cancer
  • Boston, Massachusetts
  • +2 more
Dec 7, 2019

Oral Cancer Trial in United States (Erlotinib, Placebo)

Completed
Has Results
  • Oral Cancer
  • Atlanta, Georgia
  • +3 more
Apr 13, 2020

Advanced Cancer Trial in Houston (Bevacizumab, Sorafenib, Erlotinib)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 27, 2020

Bronchioloalveolar Carcinoma, Large Cell Lung Carcinoma, Lung Adenocarcinoma Trial in Sacramento, Worcester, Bronx (Erlotinib

Completed
Has Results
  • Bronchioloalveolar Carcinoma
  • +5 more
  • Erlotinib Hydrochloride
  • +2 more
  • Sacramento, California
  • +4 more
Aug 28, 2020

Bladder Carcinoma, Recurrent Bladder Carcinoma Trial in United States (drug, other, procedure)

Terminated
Has Results
  • Bladder Carcinoma
  • Recurrent Bladder Carcinoma
  • Erlotinib Hydrochloride
  • +5 more
  • Baltimore, Maryland
  • +5 more
Jun 24, 2020

Lung Cancer Trial in Houston (Bexarotene, Erlotinib)

Completed
Has Results
  • Lung Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 17, 2020

Recurrent Bladder Urothelial Carcinoma, Recurrent Renal Pelvis Urothelial Carcinoma, Recurrent Ureter Urothelial Carcinoma Trial

Completed
Has Results
  • Recurrent Bladder Urothelial Carcinoma
  • +19 more
  • Erlotinib Hydrochloride
  • Houston, Texas
    M D Anderson Cancer Center
Aug 21, 2020

Advanced Solid Tumors Trial in United Kingdom, United States (OSI-906, erlotinib)

Completed
  • Advanced Solid Tumors
  • Aurora, Colorado
  • +3 more
Nov 14, 2019

Head Neck Cancer Trial in London, Montreal (erlotinib HCl, adjuvant therapy)

Completed
  • Head and Neck Cancer
  • erlotinib hydrochloride
  • adjuvant therapy
  • London, Canada
  • +1 more
Apr 2, 2020

Non Small Cell Lung Cancer Trial in Madison (erlotinib, sunitinib)

Completed
  • Non Small Cell Lung Cancer
  • erlotinib, sunitinib
  • Madison, Wisconsin
    University of Wisconsin Carbone Comprehensive Cancer Center
Nov 15, 2019